
Press Releases
$250M Contract
Datar Cancer Genetics Announces Foray Into The United States With A $250M Contract To Offer Pioneering Cancer Detection Liquid Biopsies
Hover to Know More
The London Clinic News
Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services
Hover to Know More
FDA News - Prostate Cancer
Datar’s TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation.
Hover to Know More
South Africa - News
Groundbreaking’ high-sensitivity cancer-screening test arriving in SA ahead of World Cancer Day.
Hover to Know More
Kuwait - News
Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait.
Hover to Know More
FDA News - Breast Cancer
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics.
Hover to Know More
The Healthcare Technology Report
The Top 25 Women Leaders in Biotechnology of 2021
(Swati Deshpande - Datar Cancer Genetics).
Hover to Know More
NICE - UK
UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer'.
Hover to Know More